ID: ALA3707026

Max Phase: Preclinical

Molecular Formula: C25H27N3O2

Molecular Weight: 401.51

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCOC(=O)c1c(N2CCN(C)CC2)nc2cccc3c2c1-c1ccccc1-3

Standard InChI:  InChI=1S/C25H27N3O2/c1-3-4-16-30-25(29)23-22-19-9-6-5-8-17(19)18-10-7-11-20(21(18)22)26-24(23)28-14-12-27(2)13-15-28/h5-11H,3-4,12-16H2,1-2H3

Standard InChI Key:  FWMRZGOXUHJQRS-UHFFFAOYSA-N

Associated Targets(non-human)

Serotonin 3 (5-HT3) receptor 1834 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 401.51Molecular Weight (Monoisotopic): 401.2103AlogP: 4.59#Rotatable Bonds: 5
Polar Surface Area: 45.67Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 7.57CX LogP: 5.33CX LogD: 4.94
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.36Np Likeness Score: -0.58

References

1. Cappelli A, Anzini M, Vomero S, Canullo L, Mennuni L, Makovec F, Doucet E, Hamon M, Menziani MC, De Benedetti PG, Bruni G, Romeo MR, Giorgi G, Donati A..  (1999)  Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptors.,  42  (9): [PMID:10229626] [10.1021/jm981112s]

Source